Chicago Partners Investment Group LLC Biomarin Pharmaceutical Inc Transaction History
Chicago Partners Investment Group LLC
- $3.16 Billion
- Q2 2025
A detailed history of Chicago Partners Investment Group LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Chicago Partners Investment Group LLC holds 6,144 shares of BMRN stock, worth $330,608. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,144Holding current value
$330,608% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
689Shares Held
187MCall Options Held
1.31MPut Options Held
1.1M-
Black Rock Inc. New York, NY22.7MShares$1.22 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.02 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$849 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$813 Million0.5% of portfolio
-
Viking Global Investors LP12.3MShares$661 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...